drugset / Trial / NCT02809105
A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to verify the efficacy and investigate the safety of the study drug when ASP0456 is administered orally for 4 weeks and 52 weeks.
Timeline
- Start
- 2016-06-24
- Primary completion
- 2016-11-14
- Completion
- 2017-11-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linaclotide | Peptide | — | Oral |